Literature DB >> 24891187

MiR-195 targets HDGF to inhibit proliferation and invasion of NSCLC cells.

Haizhou Guo1, Weihao Li, Tianliang Zheng, Zhangsuo Liu.   

Abstract

Non-small cell lung cancer (NSCLC) is one of the most common causes of cancer-related death worldwide. MicroRNAs (miRNAs) play critical roles in the development and progression of NSCLC. miR-195 acts as a tumor suppressor in several cancers, however, its role in NSCLC is not well understood. Herein, we found that miR-195 was significantly decreased in both NSCLC tissues and cell lines. Forced expression of miR-195 significantly suppressed proliferation, migration, and invasion of NSCLC cells. Hepatoma-derived growth factor (HDGF) was identified as a target of miR-195 in NSCLC cells. Overexpression of HDGF dramatically abolished the tumor suppressive role of miR-195 in NSCLC cells. Our results demonstrated a tumor suppressive role of miR-195 in NSCLC, and suggested a potential therapeutic target for NSCLC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24891187     DOI: 10.1007/s13277-014-2153-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  24 in total

Review 1.  miRNAs in lung cancer: a link to aging.

Authors:  Anna Zagryazhskaya; Boris Zhivotovsky
Journal:  Ageing Res Rev       Date:  2014-03-12       Impact factor: 10.895

2.  Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.

Authors:  Hirokazu Uyama; Yasuhiko Tomita; Hideji Nakamura; Shoji Nakamori; Binglin Zhang; Yoshihiko Hoshida; Hirayuki Enomoto; Yorihide Okuda; Masato Sakon; Katsuyuki Aozasa; Ichiro Kawase; Norio Hayashi; Morito Monden
Journal:  Clin Cancer Res       Date:  2006-10-15       Impact factor: 12.531

3.  microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN.

Authors:  Jian Hua Mao; Rong Ping Zhou; Ai Fen Peng; Zhi Li Liu; Shan Hu Huang; Xin Hua Long; Yong Shu
Journal:  Oncol Lett       Date:  2012-08-16       Impact factor: 2.967

4.  Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells.

Authors:  Yang Ke; Weiyong Zhao; Jie Xiong; Rubo Cao
Journal:  FEBS Lett       Date:  2013-08-13       Impact factor: 4.124

5.  Hepatoma-derived growth factor is involved in lung remodeling by stimulating epithelial growth.

Authors:  Masahide Mori; Hiroshi Morishita; Hideji Nakamura; Hiroto Matsuoka; Kenya Yoshida; Yoshihiko Kishima; Zhiwei Zhou; Hiroshi Kida; Toshiki Funakoshi; Sho Goya; Mitsuhiro Yoshida; Toru Kumagai; Isao Tachibana; Yoichi Yamamoto; Ichiro Kawase; Seiji Hayashi
Journal:  Am J Respir Cell Mol Biol       Date:  2003-09-11       Impact factor: 6.914

6.  MicroRNA-195 chemosensitizes colon cancer cells to the chemotherapeutic drug doxorubicin by targeting the first binding site of BCL2L2 mRNA.

Authors:  Juan Qu; Liang Zhao; Pengzhi Zhang; Juan Wang; Ning Xu; Wenjuan Mi; Xingwang Jiang; Changming Zhang; Juan Qu
Journal:  J Cell Physiol       Date:  2015-03       Impact factor: 6.384

7.  MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer.

Authors:  Hongxia Deng; Yanan Guo; Haojun Song; Bingxiu Xiao; Weiliang Sun; Zhong Liu; Xiuchong Yu; Tian Xia; Long Cui; Junming Guo
Journal:  Gene       Date:  2013-01-17       Impact factor: 3.688

8.  miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF.

Authors:  Bitao Chen; Tao Huang; Jun Jiang; Lei Lv; Hongxing Li; Shitao Xia
Journal:  Mol Cell Biochem       Date:  2013-11-26       Impact factor: 3.396

9.  Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma.

Authors:  Jhy-Shrian Huang; Chuan-Chuan Chao; Teh-Li Su; Shiou-Hwei Yeh; Ding-Shinn Chen; Chiung-Tong Chen; Pei-Jer Chen; Yuh-Shan Jou
Journal:  Biochem Biophys Res Commun       Date:  2004-03-19       Impact factor: 3.575

10.  MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.

Authors:  Wang Hui; Lu Yuntao; Luo Lun; Li WenSheng; Liang ChaoFeng; He HaiYong; Ba Yueyang
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

View more
  28 in total

1.  miR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer.

Authors:  Xiaojie Yu; Yiqiang Zhang; Xiuye Ma; Alexander Pertsemlidis
Journal:  Cancer Lett       Date:  2018-04-13       Impact factor: 8.679

2.  Circulating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancers.

Authors:  Qiang Zhao; Jun Cao; Yi-Chen Wu; Xiang Liu; Jing Han; Xian-Cong Huang; Lie-Hao Jiang; Xiu-Xiu Hou; Wei-Min Mao; Zhi-Qiang Ling
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma.

Authors:  Jou-Ho Shih; Hsin-Yi Chen; Shin-Chih Lin; Yi-Chen Yeh; Roger Shen; Yaw-Dong Lang; Dung-Chi Wu; Chien-Yu Chen; Ruey-Hwa Chen; Teh-Ying Chou; Yuh-Shan Jou
Journal:  Nucleic Acids Res       Date:  2020-02-20       Impact factor: 16.971

Review 4.  The role of miRNAs in the pheochromocytomas.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen
Journal:  Tumour Biol       Date:  2015-10-13

5.  miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.

Authors:  Xiao Xie; Hong-Tao Liu; Ju Mei; Fang-Bao Ding; Hai-Bo Xiao; Feng-Qing Hu; Rui Hu; Ming-Song Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 6.  Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy.

Authors:  Alti Dayakar; Kumar D Shanmukha; Suresh K Kalangi
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.742

7.  Hepatoma-derived growth factor: A survival-related protein in prostate oncogenesis and a potential target for vitamin K2.

Authors:  Aditya Shetty; Subramanyam Dasari; Souresh Banerjee; Taher Gheewala; Guoxing Zheng; Aoshuang Chen; Andre Kajdacsy-Balla; Maarten C Bosland; Gnanasekar Munirathinam
Journal:  Urol Oncol       Date:  2016-09-28       Impact factor: 3.498

8.  MicroRNA-27b suppresses growth and invasion of NSCLC cells by targeting Sp1.

Authors:  Jun Jiang; Xiaojuan Lv; Liang Fan; Guodong Huang; Yan Zhan; Mengyi Wang; Hongda Lu
Journal:  Tumour Biol       Date:  2014-07-11

9.  MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancer.

Authors:  Geeta Rao; Shailendra Kumar Dhar Dwivedi; Yushan Zhang; Anindya Dey; Khader Shameer; Ramachandran Karthik; Subramanya Srikantan; Md Nazir Hossen; Jonathan D Wren; Muniswamy Madesh; Joel T Dudley; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  EMBO Rep       Date:  2020-08-27       Impact factor: 9.071

10.  MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma.

Authors:  Jia Guo; Min Wang; Xiuheng Liu
Journal:  J Exp Clin Cancer Res       Date:  2015-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.